Pediatrix Medical Group, Inc. reported first‑quarter 2026 results that surpassed analysts’ expectations, with revenue of $476.2 million and adjusted earnings per share of $0.44, a beat of the consensus estimate of $0.37–$0.39.
Revenue grew 3.9% year‑over‑year to $476.2 million, driven by a 4% increase in same‑unit pricing and a modest $6 million contribution from recent acquisitions, offsetting a 1.6% decline in same‑unit patient volume.
Net income rose to $29.6 million, and diluted earnings per share were $0.36. The adjusted EPS of $0.44 exceeded the consensus estimate of $0.37–$0.39, reflecting strong pricing power and disciplined cost management.
Adjusted EBITDA for the quarter reached $58.2 million, up from $44.6 million reported in the original article, indicating margin expansion driven by higher pricing and improved collections.
Operating cash flow usage increased to $130 million from $116 million year‑over‑year, while same‑unit volume fell 1.6% and pricing grew 4%, showing that the company is maintaining profitability despite a modest decline in patient volume.
Pediatrix reaffirmed its 2026 guidance, projecting flat revenue of approximately $1.9 billion and adjusted EBITDA of $280–$300 million, signaling confidence in sustaining pricing power and operational efficiency.
Despite the earnings beat, the stock fell 6.69% in pre‑market trading and opened down about 11% on May 5, 2026, as investors weighed broader healthcare market pressures and potential moderation in cash collections and administrative fees.
CEO Mark S. Ordan said, 'Our first quarter operating results exceeded our expectations, driven by top‑line growth.' CFO Kasandra Rossi added, 'Pricing growth of 4% was driven by solid RCM cash collections, increases in contract administrative fees, favorable payer mix and increased patient acuity in neonatology, while we saw volume declines across our service lines during the quarter, including NICU days that were down about 1%.'
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.